This CTD dossier owner and manufacturer is a leading player in the nutraceutical industry, specializing in omega-3 fatty acid products derived from fish oil. With a history dating back to 1995, they have a strong track record of innovation, holding three worldwide patents for their concentrated DHA (Tridocosahexaenoina-AOX) technology. They emphasize the bioactivity of their DHA through unique cellular testing methods.The company's product portfolio spans several key therapy areas including eye health, fertility and pregnancy, neurodevelopment, immunity, and hepatology. They offer a range of dosage forms such as dietary supplements and food for special medical purposes. Their products are distributed across various regions including North America, Europe (particularly the EU), Asia, Oceania, and South America. The company is committed to quality, adhering to GMP certifications and prioritizing research and development to meet evolving market needs.